Gene therapy can viably treat mice with tuberous sclerosis complex, shows study Kumar Jeetendra | January 9, 2021 Patients with tuberous sclerosis complex, a genetic disorder characterized by the growth of noncancerous tumors in several organs of the body, have limited treatment choices. A team led by investigators at Massachusetts General Hospital (MGH) has shown that gene therapy can effectively treat mice that express one of the mutated genes that cause the disease. …
Scientists disentangle the cycle that makes virus irresistible Kumar Jeetendra | January 9, 2021 Researchers have for the first time identified how viruses like the poliovirus and the common cold virus’package up’ their genetic code, allowing them to infect cells. The findings, published today (Friday, 8 January) in the journal PLOS Pathogens by a team from the Universities of Leeds and York, open up the possibility that medication or …
UK supports Moderna COVID 19 vaccine for rollout against COVID-19 Kumar Jeetendra | January 9, 2021 The UK’s regulatory authority on Friday approved a third COVID-19 vaccine to be used in the nation, made by the firm Moderna. However, supplies of the new jab aren’t expected to be available until the spring in a few weeks’ time as the UK has pre-ordered 7 million doses. In trials with over 30,000, the …
New strain Covid cases go up to 90 in India: Health Ministry Kumar Jeetendra | January 9, 2021 The number of people infected with the newest UK-linked version of coronavirus has gone up to 90 in India, the Union Health Ministry said on Saturday. These 90 cases comprise the 82 declared by the ministry till Friday. “The total number of cases infected with the new strain of the novel coronavirus, first reported in …
BioNTech cautions against deferring second vaccine portion Kumar Jeetendra | January 5, 2021 German company BioNTech warned on Tuesday that there is no data backing the”safety and efficacy” of delaying the next shot of its COVID-19 vaccine beyond three weeks, as some countries push the jab to provide more people their first dose. BioNTech, which developed the vaccine with US giant Pfizer, said its clinical data showing 95 …
China doubles down on COVID account as WHO examination looms Kumar Jeetendra | January 5, 2021 As a team from the World Health Organization (WHO) prepares to go to China to investigate the origins of COVID-19, Beijing has stepped up efforts not only to prevent new outbreaks, but also form the story about when and where the pandemic began. China has dismissed criticism of its early handling of the coronavirus, first …
High-quality SARS-CoV-2 Antigen Protein Kits Kumar Jeetendra | January 5, 2021 AMSBIO has introduced a series of kit products based upon high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development. These new kit products include SARS-CoV-2 inhibitor screening kits, antibody titer serologic assay kits, antigen detection kit and antigen pre-coated plates. SARS-CoV-2 is an enveloped positive-stranded RNA virus that consists of …
FDA-endorsed COVID-19 medication should be utilized warily, says UC researcher Kumar Jeetendra | January 4, 2021 While the world has its eyes on vaccines to stop the spread of coronavirus, therapeutics continue to be necessary to treat hepatitis patients. One of these treatments, remdesivir, is the first and only antiviral agent of its type the U.S. Food and Drug Administration (FDA) has approved so far for COVID-19. Research at the University …
Smoking traditional cigarettes alongside e-cigarettes causes harmful wellbeing impacts Kumar Jeetendra | January 4, 2021 Smoking traditional cigarettes in addition to using e-cigarettes leads to harmful health effects like smoking cigarettes exclusively, according to new research published today in the American Heart Association’s flagship journal Circulation. Smoking, a well-known link to cardiovascular disease and death, seems to be on the decline. While using e-cigarettes, known as vaping, is increasingly popular, …
US may cut some Moderna COVID-19 antibody dosages down the middle to speed rollout: Federal authority Kumar Jeetendra | January 4, 2021 The US government is considering giving some people half the dose of Moderna’s COVID-19 vaccine in order to speed vaccinations, a federal official said on January 3. Moncef Slaoui, head of Operation Warp Speed, the federal vaccine program, said on CBS’”Face the Nation” that officials were in discussions with Moderna and the Food and Drug …
Chemotherapy drug beats remdesivir against Covid in lab tests: Study Kumar Jeetendra | January 3, 2021 A chemotherapy medication originally developed to treat cancer might potentially be repurposed to inhibit the replication of the novel coronavirus and cure COVID-19, according to a study based on computer simulations and laboratory experiments. The study, published in the journal PLOS Computational Biology, combined multiple computational methods that simulate drug-virus interactions from different, complimentary perspectives. …
An incredible achievement in India’s’ scientific fraternity capacity: Bharat Biotech on endorsement for emergency use of covaxin Kumar Jeetendra | January 3, 2021 Hyderabad, Jan 3 (PTI): Expressing delight over the approval on restricted emergency use of its COVID-19 vaccine Covaxin, Bharat Biotech on Sunday said it has generated excellent safety data with robust immune responses to multiple viral proteins that persist and their goal is to provide global access to populations that need it the most. Ella …
